KBC Group NV Sells 206,069 Shares of Davita Inc (DVA)

KBC Group NV trimmed its holdings in Davita Inc (NYSE:DVA) by 87.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,465 shares of the company’s stock after selling 206,069 shares during the period. KBC Group NV’s holdings in Davita were worth $1,516,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Quantamental Technologies LLC purchased a new position in shares of Davita during the 4th quarter valued at $34,000. Honkamp Krueger Financial Services Inc. purchased a new position in shares of Davita during the 3rd quarter valued at $143,000. Caption Management LLC grew its position in shares of Davita by 100.7% during the 4th quarter. Caption Management LLC now owns 3,200 shares of the company’s stock valued at $164,000 after purchasing an additional 488,800 shares in the last quarter. Atlas Capital Advisors LLC grew its position in shares of Davita by 247.9% during the 3rd quarter. Atlas Capital Advisors LLC now owns 2,592 shares of the company’s stock valued at $188,000 after purchasing an additional 1,847 shares in the last quarter. Finally, Contravisory Investment Management Inc. grew its position in shares of Davita by 8.2% during the 4th quarter. Contravisory Investment Management Inc. now owns 3,932 shares of the company’s stock valued at $202,000 after purchasing an additional 298 shares in the last quarter. Institutional investors and hedge funds own 85.99% of the company’s stock.

A number of research analysts have recently commented on DVA shares. Zacks Investment Research lowered shares of Davita from a “hold” rating to a “sell” rating in a research report on Tuesday, November 13th. Royal Bank of Canada reiterated a “hold” rating and issued a $65.00 target price on shares of Davita in a research report on Wednesday, January 9th. Deutsche Bank initiated coverage on shares of Davita in a research report on Thursday, January 3rd. They issued a “buy” rating and a $60.00 target price for the company. Barclays initiated coverage on shares of Davita in a research report on Friday, December 14th. They issued an “overweight” rating and a $70.00 target price for the company. Finally, ValuEngine lowered shares of Davita from a “buy” rating to a “hold” rating in a research report on Wednesday, October 17th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company. Davita has an average rating of “Hold” and a consensus price target of $71.93.

Shares of NYSE:DVA opened at $56.13 on Monday. Davita Inc has a 52-week low of $48.25 and a 52-week high of $79.11. The firm has a market capitalization of $9.32 billion, a P/E ratio of 16.91, a P/E/G ratio of 0.57 and a beta of 1.31. The company has a quick ratio of 1.82, a current ratio of 1.84 and a debt-to-equity ratio of 2.09.

TRADEMARK VIOLATION WARNING: “KBC Group NV Sells 206,069 Shares of Davita Inc (DVA)” was first published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.chaffeybreeze.com/2019/02/11/kbc-group-nv-sells-206069-shares-of-davita-inc-dva.html.

Davita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Read More: What is a Market Correction?

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply